ERBB2 and breast cancer: As 31% of TNBCs were positive for EGFR protein in this series, we measured EGFR gene copy number in 63 TNBCs compared with 42 ER and/or PgR-positive but HER2-negative consecutive breast cancers, (which are also termed luminal subtype [2]).